Bladder Cancer - Results from #380

Clinical upstaging after neoadjuvant chemotherapy impacting eligibility for vaginal-sparing cystectomy: identifying bladder cancer patients who may benefit from interim imaging. June 25, 2024

Establishing an Intravesical Doublet Chemotherapy Clinic for Nonmuscle-Invasive Bladder Cancer Patients. June 24, 2024

The Role of Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. June 24, 2024

Clinical Validation of the Intermediate-risk Non-muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group Collaboration. June 24, 2024

Diagnostic Test Accuracy of Urinary DNA Methylation-based Biomarkers for the Detection of Primary and Recurrent Bladder Cancer: A Systematic Review and Meta-analysis. June 21, 2024

CEA (CEACAM5) expression is common in muscle-invasive urothelial carcinoma of the bladder but unrelated to the disease course. June 21, 2024

Teaching hospitals and textbook outcomes after major urologic cancer surgery. June 21, 2024

Evaluating Antibody-Drug Conjugates Combination with Radiation Therapy in Bladder Cancer - Expert Commentary June 20, 2024

Treatment Patterns and Outcomes by Age in Metastatic Urinary Tract Cancer: A Retrospective Tertiary Cancer Center Analysis. June 20, 2024

Digital spatial profiling of the microenvironment of muscle invasive bladder cancer. June 20, 2024

NON-ALCOHOLIC FATTY LIVER DISEASE AND EXTRA-HEPATIC CANCER: A NARRATIVE REVIEW. June 20, 2024

Activity of Enfortumab Vedotin and Sacituzumab Govitecan with Radiation in Preclinical Models of Bladder Cancer. June 20, 2024

Enfortumab vedotin and pembrolizumab combination as a relevant game changer in urothelial carcinoma: What is left behind? June 19, 2024

On the Road Towards Curing Advanced Bladder Cancer. June 19, 2024

Avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma: real-world results from a Korean expanded access program. June 19, 2024

Beyond the Buzzwords: How AI and Advancing Diagnostic Technologies Will Transform Early Bladder Cancer Care June 18, 2024

Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience. June 18, 2024

Impact of pathologic re-review on grade, clinical stage, and risk stratification for patients with nonmuscle invasive bladder cancer. June 18, 2024

What About Variant Histologies in Bladder Cancer? June 17, 2024

A systematic review of the patient reported outcomes that affect patients with muscle invasive bladder cancer after radical cystectomy and urinary diversion. June 17, 2024

Page 20 of 522